Table 1 Clinical characteristics of the study population grouped by sexual frequency.
From: The association of sexual frequency with cardiovascular diseases incidence and all-cause mortality
Characteristic | Overall (n = 17243) | Sexual frequency, times/year | P value | |||
|---|---|---|---|---|---|---|
< 12(n = 6271) | 12–51(n = 5216) | 52–103 (n = 3289) | > 103 (n = 2467) | |||
Age, years | < 0.001*** | |||||
20–30 | 5263 (29.5%) | 1706 (26%) | 1430 (25.4%) | 1107 (33.4%) | 1020 (41.2%) | |
31–43 | 5910 (32.8%) | 1767 (27.2%) | 1905 (35%) | 1271 (35.6%) | 967 (36.8%) | |
44–59 | 6070(37.1) | 2798 (46.7%) | 1881 (39.6%) | 911 (31%) | 480 (22%) | |
Sex-male | 8649 (51%) | 3326 (53.5%) | 2462 (49.1%) | 1622 (50.5%) | 1239 (50.7%) | < 0.001*** |
Race | < 0.001*** | |||||
White | 7027 (65.2%) | 2184 (59.2%) | 2324 (69.7%) | 1451 (68.2%) | 1068 (64.4%) | |
Other | 6556 (23.1%) | 2523 (25.8%) | 1816 (19.9%) | 1254 (22.4%) | 963 (25.4%) | |
Black | 3660 (11.7%) | 1564 (15.1%) | 1076 (10.5%) | 584 (9.4%) | 436 (10.2%) | |
Education level | < 0.001*** | |||||
Below high school | 3700 (14.9%) | 1750 (19.8%) | 840 (11.3%) | 566 (11.9%) | 544 (16%) | |
High school | 3892 (21.9%) | 1477 (23.3%) | 1069 (20.6%) | 731 (20.1%) | 615 (24%) | |
Above high school | 9651 (63.3%) | 3044 (56.9%) | 3307 (68.1%) | 1992 (68%) | 1308 (60%) | |
Marital status | 9070 (56.9%) | 2617 (46%) | 3120 (64.4%) | 1977 (62.8%) | 1356 (56.4%) | < 0.001*** |
BMI, Kg/m2 | 0.2 | |||||
<25 | 5360 (32.5%) | 1894 (31.6%) | 1709 (32.9%) | 1020 (33.2%) | 737 (32.3%) | |
25–30 | 5584 (32.7%) | 2008 (31.9%) | 1664 (33%) | 1102 (34%) | 810.00 (32%) | |
>30 | 6299 (34.8%) | 2369 (36.5%) | 1843 (34.1%) | 1167 (32.8%) | 920 (35.7%) | |
Hypertension | 3928 (22%) | 1684 (25.1%) | 1196 (23%) | 619 (18.4%) | 429 (17.4%) | < 0.001*** |
Diabetes | 1641 (7.5%) | 844 (10.5%) | 421 (6.8%) | 237 (5.8%) | 139 (4.5%) | < 0.001*** |
Smoking | 7223 (43%) | 2583 (42.7%) | 2079 (41%) | 1355 (41.7%) | 1206 (50.1%) | < 0.001*** |
Drinking | < 0.001*** | |||||
Never | 4253 (19.7%) | 1872 (24.2%) | 1216 (18.8%) | 708 (17.2%) | 457(15%) | |
1-5times/month | 8873 (51.5%) | ,089 (51.4%) | 2728 (50.9%) | 1725 (51.5%) | 1,331 (53%) | |
> 5times/month | 4117 (28.8%) | 1310 (24.4%) | 1272 (30.3%) | 856 (31.4%) | 679 (32%) | |
PHQ-9 | < 0.001*** | |||||
0–9 | 15,716 (92.5%) | 5570 (90.2%) | 4818 (93.7%) | 3074 (93.9%) | 2254 (92.9%) | |
10–14 | 950 (4.72%) | 420 (6.1%) | 256 (4.2%) | 143 (3.8%) | 131 (4.3%) | |
> 15 | 577 (2.8%) | 281 (3.8%) | 142 (2.2%) | 72 (2.3%) | 82 (2.9%) | |
NLR | 0.054 | |||||
< 1.43 | 4320 (22.4%) | 1642 (22.7%) | 1271 (21.7%) | 847 (23.5%) | 560 (21.8%) | |
1.44–2.5 | 8641 (52.2%) | 3032 (50.6%) | 2640 (52.4%) | 1654 (53.1%) | 1315 (54.4%) | |
> 2.5 | 4282 (25.4%) | 1597 (26.7%) | 1305 (25.9%) | 788 (23.4%) | 592 (23.8%) | |
eGFR, ml/min/1.73m2 | < 0.001*** | |||||
< 60 | 242 (1.4%) | 133 (2%) | 66 (1.29%) | 30 (1.1%) | 13 (0.4%) | |
60–90 | 3548 (24.6%) | 1415 (26.7%) | 1147 (26.25%) | 581 (21.5%) | 405 (20.6%) | |
> 90 | 13,453 (74%) | 4723 (71.4%) | 4003 (72.45%) | 2678 (77.4%) | 2049 (79%) | |
Partnered | 11,093 (68.5%) | 3,193 (54.7%) | 3,626 (73.3%) | 2,459 (77.3%) | 1,815 (74.8%) | < 0.001*** |
Exercise, vigorous/moderate | 9,850 (71.4%) | 3,381 (67.2%) | 3,021 (70.3%) | 1,934 (73.7%) | 1,514 (76.6%) | < 0.001*** |
Homosexual behavior | 1,230 (7.7%) | 459 (8.6%) | 351 (7.0%) | 211 (6.8%) | 209 (8.9%) | 0.008** |
β-blockers | 715 (4.1%) | 341 (5.4%) | 232 (4.6%) | 79 (2.2%) | 63 (2.6%) | < 0.001*** |
Contraceptives | 684 (5.4%) | 151 (3.5%) | 244 (6.1%) | 162 (6.3%) | 127 (6.7%) | < 0.001 |
Erectile dysfunction agents | 30 (0.2%) | 7 (< 0.1%) | 13 (0.3%) | 5 (0.2%) | 5 (0.3%) | 0.2 |
CVD | 663 (3.2%) | 360 (4.8%) | 157 (2.77%) | 74 (1.9%) | 72 (2.4%) | < 0.001*** |
CVD-mortality | 120 (0.5%) | 77 (1%) | 32 (0.4%) | 5 (0.1%) | 6 (0.2%) | < 0.001*** |
All-cause mortality | 565 (2.8%) | 327 (4.6%) | 127 (2%) | 56 (1.6%) | 55 (2.4%) | < 0.001*** |
Cancer | 650 (4.8%) | 266 (5.3%) | 206 (5.3%) | 107 (4.3%) | 71 (3.4%) | 0.020* |
Chronic bronchitis | 799 (4.8%) | 306 (5%) | 251 (5.2%) | 115 (3.3%) | 127 (5.4%) | 0.008** |
Age, years | 38.69 (11.31) | 40.68 (11.98) | 39.46 (10.92) | 37.02 (10.76) | 34.70 (9.97) | < 0.001*** |
PIR | 3.03 (1.67) | 2.80 (1.69) | 3.32 (1.61) | 3.04 (1.64) | 2.84 (1.67) | < 0.001*** |
BMI, Kg/m2 | 28.73 (6.88) | 29.07 (7.32) | 28.60 (6.67) | 28.50 (6.64) | 28.56 (6.60) | 0.026* |
SBP, mmHg | 118.04 (14.05) | 119.78 (15.53) | 117.55 (13.69) | 117.05 (12.87) | 116.55 (12.43) | < 0.001*** |
DBP, mmHg | 70.90 (11.23) | 71.11 (11.82) | 71.25 (10.94) | 70.62 (10.73) | 69.97 (11.13) | < 0.001*** |
Cr, ummol/L | 76.20 (26.30) | 77.40 (32.66) | 75.94 (25.51) | 75.07 (18.25) | 75.65 (20.65) | 0.083 |
HbA1c, % | 5.46 (0.86) | 5.59 (1.01) | 5.42 (0.77) | 5.39 (0.73) | 5.35 (0.78) | < 0.001*** |
HDL, mmol/L | 1.36 (0.42) | 1.35 (0.42) | 1.38 (0.43) | 1.36 (0.42) | 1.33 (0.39) | 0.007** |
TC, mmol/L | 5.02 (1.06) | 5.03 (1.06) | 5.06 (1.10) | 4.99 (1.02) | 4.93 (1) | < 0.001*** |
NE, ×109 | 4.37 (1.74) | 4.36 (1.80) | 4.34 (1.73) | 4.36 (1.68) | 4.44 (1.69) | 0.013* |
LY, ×109 | 2.19 (0.82) | 2.18 (0.77) | 2.16 (0.98) | 2.21 (0.67) | 2.24 (0.69) | < 0.001*** |
WBC, ×109 | 7.35 (2.21) | 7.33 (2.26) | 7.30 (2.27) | 7.37 (2.11) | 7.49 (2.11) | < 0.001*** |
eGFR, ml/min/1.73m2 | 101.65 (18.53) | 100.46 (19.45) | 100.67 (18.20) | 103.22 (17.84) | 104.44 (17.59) | < 0.001*** |
